Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849563 · ClinicalTrials.gov registry record · NA
Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT00849563 is a NA study that has completed, run by Duke University. The registered enrollment target is 450 participants.
The verdict
NCT00849563, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
The primary objective of the study is to assess the clinical utility of a genetic test for Type 2 diabetes risk in combination with standardized risk assessment compared with standardized risk assessment alone, and to measure whether changes in perceived risk following genetic testing for Type 2 diabetes risk are correlated with behavior change and increased concern about risk for Type 2 diabetes.
Interventions
- OTHER Standardized Risk Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00849563
The ClinicalTrials.gov registry entry for NCT00849563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standardized Risk Assessment is the first listed.
NCT00849563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00849563 about?
NCT00849563 is a clinical study titled "Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes". The primary objective of the study is to assess the clinical utility of a genetic test for Type 2 diabetes risk in combination with standardized risk assessment compared with standardized risk assessment alone, and to measure whether changes in perceived risk following genetic testing for Type 2 dia...
What is the current status of trial NCT00849563?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2009-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00849563?
The interventions under investigation include: Standardized Risk Assessment (OTHER).
Who is sponsoring clinical trial NCT00849563?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.